Owl Creek Asset Management L.P. Buys New Stake in Intuitive Surgical, Inc. $ISRG

Owl Creek Asset Management L.P. purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 1st quarter, Holdings Channel.com reports. The firm purchased 17,069 shares of the medical equipment provider’s stock, valued at approximately $7,869,000. Intuitive Surgical accounts for approximately 0.6% of Owl Creek Asset Management L.P.’s holdings, making the stock its 15th biggest position.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Lazard Asset Management LLC raised its holdings in shares of Intuitive Surgical by 18.3% in the 1st quarter. Lazard Asset Management LLC now owns 648,649 shares of the medical equipment provider’s stock worth $299,021,000 after buying an additional 100,428 shares in the last quarter. ABS Direct Equity Fund LLC acquired a new stake in Intuitive Surgical in the 1st quarter valued at $163,000. Family Manage LLC boosted its stake in Intuitive Surgical by 15.9% in the 1st quarter. Family Manage LLC now owns 874 shares of the medical equipment provider’s stock valued at $403,000 after buying an additional 120 shares in the last quarter. Gateway Wealth Partners LLC bought a new stake in Intuitive Surgical in the first quarter valued at $409,000. Finally, Blue Chip Partners LLC grew its position in Intuitive Surgical by 6.0% in the first quarter. Blue Chip Partners LLC now owns 2,274 shares of the medical equipment provider’s stock valued at $1,048,000 after acquiring an additional 129 shares during the period. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ISRG. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a report on Thursday, April 23rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. Sanford C. Bernstein dropped their target price on shares of Intuitive Surgical from $750.00 to $685.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Finally, Piper Sandler restated an “overweight” rating and issued a $470.00 price target (down from $580.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Twenty-one research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $523.46.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $337.50 on Monday. The stock’s fifty day moving average is $406.88 and its 200-day moving average is $459.23. The stock has a market capitalization of $119.23 billion, a PE ratio of 38.66, a PEG ratio of 2.44 and a beta of 1.46. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The company had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same period last year, the company posted $1.81 earnings per share. The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. As a group, analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical unveiled a five-layer AI framework for its surgical platforms and demonstrated live telesurgical collaboration, signaling that it is embedding AI into clinical workflows and expanding the capabilities of its robotic surgery ecosystem. Intuitive Surgical (ISRG) Unveils Five Layer AI Plan And Live Telesurgery Demo
• Positive Sentiment: Several analyst-focused pieces framed ISRG as a strong long-term MedTech growth name, highlighting its innovation pipeline, recurring revenue, and high switching costs for surgeons. Why Intuitive Surgical, Inc. (ISRG) is a Top Growth Stock for the Long-Term
• Positive Sentiment: Coverage around Wall Street recommendations continued to describe Intuitive Surgical as a favored investment idea, supporting sentiment around the company’s durable business model. Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?
• Positive Sentiment: CONMED’s expanded AirSeal indication for da Vinci 5 compatibility may help broaden use across Intuitive Surgical’s platform, reinforcing the ecosystem around its robotic systems. CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula
• Neutral Sentiment: Intuitive Surgical remains a frequent subject of analyst and stock-report coverage, but these pieces are mostly commentary rather than new fundamentals, so they are unlikely to move the stock on their own. Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors
• Neutral Sentiment: Short-interest data showed no meaningful change in reported shares, offering little direct signal for investors.
• Negative Sentiment: Some articles emphasized that ISRG’s shares have pulled back sharply and questioned whether growth expectations in its biggest market are changing, which can weigh on sentiment. Intuitive Surgical Stock Is On Sale, But Is the Growth Story Changing?
• Negative Sentiment: J&J’s progress on Ottava was viewed as a reminder that competition in robotic surgery is intensifying, adding pressure to Intuitive Surgical’s market leadership narrative. J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the sale, the executive vice president owned 5,720 shares in the company, valued at approximately $2,426,080.80. This trade represents a 6.54% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the business’s stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the transaction, the director directly owned 120 shares of the company’s stock, valued at approximately $55,620. This represents a 49.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 7,169 shares of company stock valued at $3,059,135 in the last 90 days. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.